Free Trial

BKV (NYSE:BKV) Reaches New 52-Week Low - Should You Sell?

BKV logo with Energy background
Image from MarketBeat Media, LLC.

Key Points

  • BKV shares fell to a new 52-week low of $20.15, below their 50-day and 200-day moving averages, despite the company’s $2.24 billion market capitalization and relatively low price-to-earnings ratio of 7.46.
  • Analysts remain broadly positive, with a consensus “Buy” rating and a $33.67 price target—substantially above the recent share price. Recent ratings included upgrades from Zacks Research and Evercore, although Susquehanna lowered its target to $35.
  • BKV exceeded quarterly expectations, reporting $0.46 in earnings per share versus a $0.25 estimate and $465.54 million in revenue versus a $355.25 million consensus forecast. However, insiders sold 35,626 shares worth about $901,589 over the past 90 days.
  • MarketBeat previews top five stocks to own in November.

BKV Corporation (NYSE:BKV - Get Free Report)'s share price reached a new 52-week low during trading on Monday. The stock traded as low as $20.15 and last traded at $20.3170, with a volume of 6,146 shares changing hands. The stock had previously closed at $20.36.

Analyst Upgrades and Downgrades

A number of analysts have recently issued reports on the company. Weiss Ratings cut BKV from a "hold (c+)" rating to a "hold (c)" rating in a report on Friday. Zacks Research upgraded BKV from a "hold" rating to a "strong-buy" rating in a research note on Tuesday, October 6th. Susquehanna decreased their target price on BKV from $37.00 to $35.00 and set a "positive" rating for the company in a research report on Tuesday, July 21st. Evercore upgraded BKV to a "strong-buy" rating in a report on Friday, September 18th. Finally, Jefferies Financial Group restated a "buy" rating and issued a $34.00 price target on shares of BKV in a report on Friday, July 10th. Two equities research analysts have rated the stock with a Strong Buy rating, eight have assigned a Buy rating and one has assigned a Hold rating to the stock. According to MarketBeat.com, BKV has a consensus rating of "Buy" and a consensus price target of $33.67.

Check Out Our Latest Stock Report on BKV

BKV Stock Performance

The company has a market capitalization of $2.24 billion, a price-to-earnings ratio of 7.46 and a beta of 1.13. The stock has a 50-day simple moving average of $23.67 and a 200-day simple moving average of $25.64. The company has a current ratio of 1.15, a quick ratio of 1.10 and a debt-to-equity ratio of 0.45.

BKV (NYSE:BKV - Get Free Report) last released its earnings results on Thursday, August 6th. The company reported $0.46 earnings per share for the quarter, topping the consensus estimate of $0.25 by $0.21. The company had revenue of $465.54 million during the quarter, compared to the consensus estimate of $355.25 million. BKV had a net margin of 17.73% and a return on equity of 6.67%. On average, analysts anticipate that BKV Corporation will post 1.49 earnings per share for the current year.

Insider Activity

In other news, SVP Javier Hinojosa sold 7,428 shares of the business's stock in a transaction that occurred on Friday, September 25th. The stock was sold at an average price of $22.66, for a total value of $168,318.48. Following the completion of the sale, the senior vice president directly owned 76,848 shares in the company, valued at approximately $1,741,375.68. The trade was a 8.81% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CFO David Tameron sold 1,500 shares of the company's stock in a transaction that occurred on Friday, August 21st. The shares were sold at an average price of $25.63, for a total value of $38,445.00. Following the sale, the chief financial officer directly owned 57,024 shares in the company, valued at approximately $1,461,525.12. This represents a 2.56% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last ninety days, insiders sold 35,626 shares of company stock worth $901,589. 2.51% of the stock is currently owned by insiders.

Institutional Trading of BKV

Several institutional investors have recently added to or reduced their stakes in the business. BlackRock Inc. acquired a new stake in shares of BKV during the second quarter worth $74,241,000. Cooper Creek Partners Management LLC boosted its stake in BKV by 24.7% in the first quarter. Cooper Creek Partners Management LLC now owns 2,103,230 shares of the company's stock valued at $59,984,000 after acquiring an additional 416,281 shares during the period. William Blair Investment Management LLC acquired a new position in BKV in the second quarter valued at approximately $32,689,000. Value Aligned Research Advisors LLC grew its holdings in shares of BKV by 110.5% during the second quarter. Value Aligned Research Advisors LLC now owns 679,899 shares of the company's stock valued at $18,602,000 after purchasing an additional 356,848 shares during the last quarter. Finally, Bank of America Corp DE acquired a new stake in shares of BKV during the 2nd quarter worth approximately $16,177,000.

About BKV

(Get Free Report)

BKV Corporation is an independent energy company focused on the exploration, development and production of natural gas in the United States. The company's operations are centered on unconventional shale resources, with activities that include drilling, well completion, production and management of natural gas assets.

In addition to its upstream operations, BKV is developing complementary energy businesses, including natural gas power generation and carbon capture, utilization and storage.

Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in BKV Right Now?

Before you consider BKV, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and BKV wasn't on the list.

While BKV currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Blue-Chip Stocks to Add To Your Forever Portfolio Cover

A strong long-term portfolio starts with companies that can survive recessions, inflation, changing consumer habits, and shifting market leadership.

This report names seven blue-chip stocks across technology, retail, consumer staples, healthcare, networking, sporting goods, and utilities that offer investors a mix of stability, income, growth, and staying power.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines